Where does UNIVERSITÉ Libre DE Bruxelles rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), UNIVERSITÉ Libre DE Bruxelles ranks #7,210 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does UNIVERSITÉ Libre DE Bruxelles hold?

UNIVERSITÉ Libre DE Bruxelles holds 46 US utility patents granted between 2015 and 2025, spanning 48 technology areas.

What is UNIVERSITÉ Libre DE Bruxelles's Innovation Score?

UNIVERSITÉ Libre DE Bruxelles has an Innovation Score of 57.9 out of 100 (top 5% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does UNIVERSITÉ Libre DE Bruxelles focus on?

UNIVERSITÉ Libre DE Bruxelles's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 12 patents, ranking #1,593 of 6,058 assignees active in that subclass. Grants appear in 48 CPC subclasses total.

Is UNIVERSITÉ Libre DE Bruxelles's patent grant rate increasing or decreasing?

UNIVERSITÉ Libre DE Bruxelles's recent grant velocity is -40% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for UNIVERSITÉ Libre DE Bruxelles's patents?

UNIVERSITÉ Libre DE Bruxelles's patents average 16.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the UNIVERSITÉ Libre DE Bruxelles patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

UNIVERSITÉ Libre DE Bruxelles

USPTO PatentsView assignee record - 46 granted patents across 48 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Université ranks #7,210 of 49,997 tracked US assignees by granted-patent volume, with 46 patents across 48 technology areas.

#7,210
of 49,997 US assignees by volume: Top 5%
by Innovation Score (57.9/100): 16.0
avg claims per patent: -40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7210 · Foreign Corporation #7,210 · 46 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 46 grants
UPPER-Q #7,210/49,997
PHOTO-FINISH Tomey
CPC-WIDE A61P · 48 areas
INNOV-PAR 57.9/100
CLAIMS-RICH 16.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Tomey Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Université’s 57.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.3 pts (23%) Velocity 10.5 pts (18%) Breadth 24.5 pts (42%) Claim depth 9.6 pts (17%)

Qualcomm Incorporated · highest

85
Ethernovia · near

58
UNIVERSITÉ Libre DE… · this assignee

58
Velcro IP Holdings · near

58
Welch Allyn · near

58
Cerence Operating · near

58
3D Lighting… · lowest

7

What this shows Université's Innovation Score is 57.9/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Université?

Each dot is one of Université’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Université’s own 16.0 claims/patent is ABOVE the 14.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Université vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Université's grants concentrate

UNIVERSITÉ Libre DE Bruxelles is a focused PatentsView assignee: 48 CPC subclasses with 26.1% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (9 grants) versus a trough of 1 in 2020. By volume, Université sits between Tomey Corporation and Vishay Dale Electronics, LLC.

Université's three-year grant acceleration

UNIVERSITÉ Libre DE Bruxelles shows 11 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Tomey

46
UMC Utrecht Holdi…

46
Unity Opto Techno…

46
University Colleg…

46
UPM Raflatac OY

46
Unigen

46
Vanrx Pharmasyste…

46
Vishay Dale

46
UniversitÉ Libre… ◀

46

What this shows UNIVERSITÉ holds 46 patents at rank #7,208, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near UNIVERSITÉ

By rank, the assignees closest to #7,208 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in UNIVERSITÉ's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for UNIVERSITÉ, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), UNIVERSITÉ ranks #1,593 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (58 here).

Velcro IP Holdings LLC 58 Welch Allyn, Inc. 58 Cerence Operating Company 58 Ethernovia Inc. 58

Université's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

58 Top 5% higher than 95% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

UNIVERSITÉ Libre DE Bruxelles patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	19.6%
2016	3	6.5%
2017	5	10.9%
2018	5	10.9%
2019	3	6.5%
2020	1	2.2%
2021	3	6.5%
2022	3	6.5%
2023	2	4.3%
2024	6	13.0%
2025partial year	6	13.0%

Which technologies does UNIVERSITÉ Libre DE Bruxelles patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 12

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 8

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

C07K - Peptides 6

C07D - Heterocyclic Compounds 4

A61B - DIAGNOSIS; SURGERY; Identification 4

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

G03H - Holographic Processes OR Apparatus 3

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 2

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 2

C07C - Acyclic OR Carbocyclic Compounds 2

Y10T - Technical Subjects Covered BY Former US Classification 2

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

Top 15 of 48 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

UNIVERSITÉ Libre DE Bruxelles's patent record in context - here's where to go next.

UNIVERSITÉ Libre DE Bruxelles's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 26.1% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #7,210 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare UNIVERSITÉ Libre DE Bruxelles against Tomey Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 57.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.